Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Daniel Martín, Maureen G. Maguire, Stuart L. Fine, Gui‐Shuang Ying, Glenn J. Jaffe, Juan E. Grunwald, Cynthia A. Toth, Maryann Redford, Frederick L. Ferris
Topics & Concepts
MedicineRanibizumabBevacizumabMacular degenerationRegimenVisual acuityRandomized controlled trialDosingConfidence intervalOphthalmologyClinical trialInternal medicineChemotherapyRetinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Imaging and Analysis